Kevin Rogers, MD
Director of Vascular Medicine and Intervention

The Vascular Medicine and Intervention Program within the Division of Cardiology at the University of Colorado School of Medicine is highly involved in the care of patients with a wide spectrum of non-coronary vascular diseases and collaborates with the Rocky Mountain Veteran Affairs Medical Center and the Denver Health hospital.  Across these institutions, we offer comprehensive clinical care and are engaged in a wide breadth of academic pursuits, including collaboration with CPC Clinical Research and training upcoming vascular medicine specialists and interventional cardiologists.

The clinical focus of the Vascular Medicine and Intervention section at the University of Colorado Hospital currently is the outpatient care of all types of vascular disease including occlusive and aneurysmal atherosclerotic diseases (carotid, vertebral, renal, mesenteric, aortic, and peripheral), non-atherosclerotic diseases (fibromuscular dysplasia, complications from vasculitis, and popliteal entrapment), venous diseases (thromboembolic, central venous compressive disorders such as thoracic outlet syndrome and May-Thurner syndrome, and chronic venous insufficiency) and vasospastic disorders such as Raynaud’s.  Vascular Medicine and Intervention also provides inpatient consultation, both at the University of Colorado Hospital and at our affiliated hospitals.

We offer exemplary catheter-based, revascularization for a variety of acute and chronic vascular disorders at our hospitals.  These procedures span a wide variety of vascular beds, including emerging therapies such as balloon pulmonary angioplasty (BPA) for chronic thrombo-embolic disease (CTEPH) and renal denervation (RDN).  We also perform endovascular treatment for carotid, subclavian, mesenteric, renal, and mesenteric arterial disease.

CPC Clinical Research is an academic research organization affiliated with the University of Colorado School of Medicine and is highly engaged in all aspects of clinical vascular research.  Dr. Marc Bonaca is the Executive Director of the CPC, Connie Hess, MD MHS a lead clinician scientist, and Kevin Rogers, MD MSc also a clinician scientist with CPC Clinical Research. Additionally, the University of Colorado is a site for the International Spontaneous Coronary Artery Disease registry and the United States Fibromuscular Dysplasia Registry. Stephen Waldo, MD leads quality in outcomes research at a national level for the Veterans Affairs medical system. 

The faculty in the Vascular Medicine and Interventional program at the University of Colorado School of Medicine and affiliated hospitals continue to contribute to excellent evidence-based care of patients with vascular disease and advancing the field academically.

Meet Our Team

	Marc Bonaca, MD Professor, Medicine-Cardiology
	Connie Hess, MD Associate Professor, Medicine-Cardiology
	Stephen Waldo, MD Professor, Medicine-Cardiology